Home/Filings/4/0001209191-19-024105
4//SEC Filing

Biller Scott 4

Accession 0001209191-19-024105

CIK 0001439222other

Filed

Apr 8, 8:00 PM ET

Accepted

Apr 9, 4:59 PM ET

Size

12.2 KB

Accession

0001209191-19-024105

Insider Transaction Report

Form 4
Period: 2019-04-05
Biller Scott
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Common stock

    2019-04-05$39.76/sh+3,000$119,28029,511 total
  • Exercise/Conversion

    Stock option (right to buy)

    2019-04-053,00039,648 total
    Exercise: $39.76Exp: 2026-02-15Common stock (3,000 underlying)
  • Sale

    Common stock

    2019-04-05$67.61/sh2,401$162,33227,110 total
  • Sale

    Common stock

    2019-04-05$68.12/sh599$40,80426,511 total
Holdings
  • Common stock

    (indirect: See footnote)
    53,059
Footnotes (6)
  • [F1]This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • [F2]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • [F3]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $67.00 to $67.99. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F4]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $68.00 to $68.27. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F5]Shares held by a trust, of which the reporting person is trustee and beneficiary.
  • [F6]This option was granted on February 16, 2016. The shares underlying this option vest as to 25% of the underlying shares on February 16, 2017, with the remaining 75% vesting in 36 equal monthly installments thereafter.

Issuer

AGIOS PHARMACEUTICALS INC

CIK 0001439222

Entity typeother

Related Parties

1
  • filerCIK 0001581956

Filing Metadata

Form type
4
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 4:59 PM ET
Size
12.2 KB